Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
MBX.TOthis companyMicrobix Biosystems Inc.	CA$0.29	-16.46×	1.33×	1.98×	73.63×	-10.7%	53.0%	-8.5%	-12.1%	-8.1%	-4.4%	-2.4%	0.24×	-12.48×	-1.66×	8.48×	0.0%	3	1.64	2	C
ADK.VDIAGNOS Inc.	CA$0.36	-6.52×	43.19×	453.09×	-7.44×	-103.4%	-182.4%	-6510.6%	-6956.9%	-663.2%	-204.1%	-13.5%	2.04×	-0.26×	-11.06×	1.49×	0.0%	4	-25.01	1	D+
BCT.TOBriaCell Therapeutics Corp.	CA$5.57	-0.68×	1.47×	0×	-0.39×	-83.3%	0.0%	0.0%	0.0%	-216.0%	-234.6%	-120.9%	0×	0.27×	0×	2.76×	0.0%	1	-10.15	2	C
BUX.CNBioMark Diagnostics Inc.	CA$0.45	-40.43×	180.94×	1,001.91×	-40.29×	-101.2%	-539.4%	-3130.7%	-2470.8%	-446.2%	-163.3%	-1.8%	2.19×	-0.07×	-29.59×	0.99×	0.0%	1	4.74	1	D+
DOSE.CNRapid Dose Therapeutics Corp.	CA$0.11	-5.88×	-2.78×	7.19×	-15.23×	-398.4%	-34.5%	-78.3%	-122.2%	47.2%	117.1%	-1.4%	-0.74×	-3.2×	-1.78×	0.04×	0.0%	3	-27.84	2	C
DTC.CNDefence Therapeutics Inc.	CA$0.36	-4×	7.79×	0×	-5.53×	-98.2%	0.0%	0.0%	0.0%	-190.7%	-94.2%	-17.4%	0.49×	0.03×	-12.15×	3.42×	0.0%	2	-5.63	1	C-
Peer median	—	-5.88×	7.79×	7.19×	-7.44×	-101.2%	-34.5%	-78.3%	-122.2%	-216.0%	-163.3%	-13.5%	0.49×	-0.07×	-11.06×	1.49×	0.0%	2	-10.15	1	—